<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
<record>
  <controlfield tag="001">131170</controlfield>
  <controlfield tag="005">20250130163245.0</controlfield>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="2">doi</subfield>
    <subfield code="a">10.2337/dc18-1410</subfield>
  </datafield>
  <datafield tag="024" ind1="8" ind2=" ">
    <subfield code="2">sideral</subfield>
    <subfield code="a">110368</subfield>
  </datafield>
  <datafield tag="037" ind1=" " ind2=" ">
    <subfield code="a">ART-2019-110368</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Laclaustra, M.</subfield>
    <subfield code="0">(orcid)0000-0003-3963-0846</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019</subfield>
  </datafield>
  <datafield tag="506" ind1="0" ind2=" ">
    <subfield code="a">Access copy available to the general public</subfield>
    <subfield code="f">Unrestricted</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
    <subfield code="a">OBJECTIVE: Diabetes prevalence and incidence increase among individuals with hypothyroidism but also among those with hyperthyroxinemia, which seems contradictory. Both high free thyroxine (fT4) and high thyroid-stimulating hormone (TSH) are present in the resistance to thyroid hormone syndrome. A mild acquired resistance to thyroid hormone might occur in the general population and be associated with diabetes. We aimed to analyze the association of resistance to thyroid hormone indices (the Thyroid Feedback Quantile-based Index [TFQI], proposed in this work, and the previously used Thyrotroph T4 Resistance Index and TSH Index) with diabetes. RESEARCH DESIGN AND METHODS: We calculated the aforementioned resistance to thyroid hormone indices based on a U.S. representative sample of 5, 129 individuals =20 years of age participating in the 2007-2008 National Health and Nutrition Examination Survey (NHANES). Also, to approximate TFQI, a U.S.-referenced Parametric TFQI (PTFQI) can be calculated with the spreadsheet formula =NORM.DIST(fT4_cell_in_pmol_per_L, 10.075, 2.155, TRUE)+NORM.DIST(LN(TSH_cell_in_mIU_per_L), 0.4654, 0.7744, TRUE)-1. Outcomes of interest were glycohemoglobin =6.5%, diabetes medication, diabetes-related deaths (diabetes as contributing cause of death), and additionally, in a fasting subsample, diabetes and metabolic syndrome. Logistic and Poisson regressions were adjusted for sex, age, and race/ethnicity. RESULTS: Odd ratios for the fourth versus the first quartile of TFQI were 1.73 (95% CI 1.32, 2.27) (Ptrend = 0.002) for positive glycohemoglobin and 1.66 (95% CI 1.31, 2.10) (Ptrend = 0.001) for medication. Diabetes-related death rate ratio for TFQI being above versus below the median was 4.81 (95% CI 1.01, 22.94) (Ptrend = 0.015). Further adjustment for BMI and restriction to normothyroid individuals yielded similar results. Per 1 SD in TFQI, odds increased 1.13 (95% CI 1.02, 1.25) for diabetes and 1.16 (95% CI 1.02, 1.31) for metabolic syndrome. The other resistance to thyroid hormone indices showed similar associations for diabetes-related deaths and metabolic syndrome. CONCLUSIONS: Higher values in resistance to thyroid hormone indices are associated with obesity, metabolic syndrome, diabetes, and diabetes-related mortality. Resistance to thyroid hormone may reflect energy balance problems driving type 2 diabetes. These indices may facilitate monitoring treatments focused on energy balance.</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="9">info:eu-repo/grantAgreement/EUR/ERDF-ESF/Investing in your future</subfield>
    <subfield code="9">info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI14-00009</subfield>
    <subfield code="9">info:eu-repo/grantAgreement/ES/ISCIII-FIS/PI17-01709</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="9">info:eu-repo/semantics/openAccess</subfield>
    <subfield code="a">by</subfield>
    <subfield code="u">http://creativecommons.org/licenses/by/3.0/es/</subfield>
  </datafield>
  <datafield tag="590" ind1=" " ind2=" ">
    <subfield code="a">16.019</subfield>
    <subfield code="b">2019</subfield>
  </datafield>
  <datafield tag="591" ind1=" " ind2=" ">
    <subfield code="a">ENDOCRINOLOGY &amp; METABOLISM</subfield>
    <subfield code="b">4 / 143 = 0.028</subfield>
    <subfield code="c">2019</subfield>
    <subfield code="d">Q1</subfield>
    <subfield code="e">T1</subfield>
  </datafield>
  <datafield tag="592" ind1=" " ind2=" ">
    <subfield code="a">6.48</subfield>
    <subfield code="b">2019</subfield>
  </datafield>
  <datafield tag="593" ind1=" " ind2=" ">
    <subfield code="a">Advanced and Specialized Nursing</subfield>
    <subfield code="c">2019</subfield>
    <subfield code="d">Q1</subfield>
  </datafield>
  <datafield tag="593" ind1=" " ind2=" ">
    <subfield code="a">Internal Medicine</subfield>
    <subfield code="c">2019</subfield>
    <subfield code="d">Q1</subfield>
  </datafield>
  <datafield tag="593" ind1=" " ind2=" ">
    <subfield code="a">Endocrinology, Diabetes and Metabolism</subfield>
    <subfield code="c">2019</subfield>
    <subfield code="d">Q1</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="4">
    <subfield code="a">info:eu-repo/semantics/article</subfield>
    <subfield code="v">info:eu-repo/semantics/acceptedVersion</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Moreno-Franco, B.</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0003-0604-5042</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Lou-Bonafonte, J.M.</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0001-9578-6525</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Mateo-Gallego, R.</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0001-6650-8294</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Casasnovas, J.A.</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0002-9887-2629</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Guallar-Castillon, P.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cenarro, A.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Civeira, F.</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0001-7043-0952</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="1">1006</subfield>
    <subfield code="2">255</subfield>
    <subfield code="a">Universidad de Zaragoza</subfield>
    <subfield code="b">Dpto. Fisiatría y Enfermería</subfield>
    <subfield code="c">Área Enfermería</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="1">1005</subfield>
    <subfield code="2">410</subfield>
    <subfield code="a">Universidad de Zaragoza</subfield>
    <subfield code="b">Dpto. Farmacología y Fisiolog.</subfield>
    <subfield code="c">Área Fisiología</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="1">1007</subfield>
    <subfield code="2">610</subfield>
    <subfield code="a">Universidad de Zaragoza</subfield>
    <subfield code="b">Dpto. Medicina, Psiqu. y Derm.</subfield>
    <subfield code="c">Area Medicina</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="1">1008</subfield>
    <subfield code="2">615</subfield>
    <subfield code="a">Universidad de Zaragoza</subfield>
    <subfield code="b">Dpto. Microb.Med.Pr.,Sal.Públ.</subfield>
    <subfield code="c">Área Medic.Prevent.Salud Públ.</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="g">42, 2 (2019), 303-310</subfield>
    <subfield code="p">Diabetes care</subfield>
    <subfield code="t">Diabetes care</subfield>
    <subfield code="x">0149-5992</subfield>
  </datafield>
  <datafield tag="787" ind1=" " ind2=" ">
    <subfield code="t">Supplementary material</subfield>
    <subfield code="w">https://doi.org/10.2337/dc18-1410/-/DC1</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">932882</subfield>
    <subfield code="u">http://zaguan.unizar.es/record/131170/files/texto_completo.pdf</subfield>
    <subfield code="y">Postprint</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">859322</subfield>
    <subfield code="u">http://zaguan.unizar.es/record/131170/files/texto_completo.jpg?subformat=icon</subfield>
    <subfield code="x">icon</subfield>
    <subfield code="y">Postprint</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zaguan.unizar.es:131170</subfield>
    <subfield code="p">articulos</subfield>
    <subfield code="p">driver</subfield>
  </datafield>
  <datafield tag="951" ind1=" " ind2=" ">
    <subfield code="a">2025-01-30-16:31:06</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">ARTICLE</subfield>
  </datafield>
</record>
</collection>